my account
username:
password:
American Samoa Commonwealth of the Northern Mariana Island Guam Republic of the Marshall Islands Republic of Palau
 

LIVER Cancer Home * For Practitioners * For Program Managers * For Community * Home

 

LIVER CANCER - for Program Managers and Coalition Members

Liver cancer kills 500,000 people around the world each year, and the hepatitis B virus (HBV) is the cause of most of these cancers, making it the second-most prevalent cause of cancer after tobacco smoke. To prevent infections by HBV, children in LMCs should be vaccinated at birth - something that is done regularly in high-income countries but is still relatively rare in others, particularly the poorest and hardest hit by the virus. A three-dose series of the vaccine costs less than $2 through Unicef and can be subsidized by the Global Alliance for Vaccines and Immunization. (source: UICC)

Hepatocellular carcinoma (HCC) is the 3rd leading cause of death by cancer worldwide and 80% of these deaths occur in low resource countries. The main risk factors, namely, the combinations between hepatitis viral infections and various environmental factors, are, in theory, preventable. It is time to consider developing a global effort aimed at significantly reducing the burden of this cancer within the next generation, taking into account that this cancer is particularly difficult to treat. This will require a much improved understanding of the geographic, pathological, virological and molecular diversity of the disease, as well as the identification of reliable biomarkers for risk assessment, early detection and monitoring of the disease.

Developing such an effort is the main objective of the International Liver Cancer Study (ILCS), a network of clinicians, epidemiologists and molecular biologists coordinated by the International Agency for Research on Cancer (IARC).

Chronic liver disease and cancer

Hepatitis B and hepatitis C viruses can result in chronic liver disease and liver cancer. Hepatitis C virus is also associated with a particular type of arthritis, as well as a disease of the blood vessels (vasculitis), cryoglobulinemia (a blood disorder) and peripheral neuropathy (disease resulting in pain, numbness, and altered sensations). (Source: CDC)

Having hepatitis or cirrhosis can increase the risk of developing liver cancer.

Anything that increases the chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. People who think they may be at risk should discuss this with their doctor. Risk factors for liver cancer include :

  • Having hepatitis B or hepatitis C; having both hepatitis B and hepatitis C increases the risk even more.
  • Having a close relative with both hepatitis and liver cancer.
  • Having cirrhosis, which can be caused by:
  • Hepatitis (especially hepatitis C).
  • Drinking large amounts of alcohol for many years or being an alcoholic.
  • Eating foods tainted with aflatoxin (poison from a fungus than can grow on foods, such as grains and nuts, that have not been stored properly).

Tests are used to screen for different types of cancer

Some screening tests are used because they have been shown to be helpful both in finding cancers early and in decreasing the chance of dying from these cancers. Other tests are used because they have been shown to find cancer in some people; however, it has not been proven in clinical trials that use of these tests will decrease the risk of dying from cancer.

Scientists study screening tests to find those with the fewest risks and most benefits. Cancer screening trials also are meant to show whether early detection (finding cancer before it causes symptoms) decreases a person's chance of dying from the disease. For some types of cancer, the chance of recovery is better if the disease is found and treated at an early stage. Clinical trials that study cancer screening methods are taking place in many parts of the country. Information about ongoing clinical trials is available from the NCI Web site.

There is no standard or routine screening test for liver cancer

Although there are no standard or routine screening tests for liver cancer, the following tests are being used or studied to screen for it:

Ultrasound

Ultrasound is a procedure in which high-energy sound waves (ultrasound) are bounced off the liver and make echoes. The echoes form a picture of the liver called a sonogram. The picture can be printed to be looked at later.

CT scan

CT scan is a procedure that makes a series of detailed pictures of the liver, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the liver show up more clearly. This procedure is also called CAT scan or computed tomography.

Tumor markers

Tumor markers, also called biomarkers, are substances made by the tumor that may be found in the blood, other body fluids, or tissues. A high level of a specific tumor marker may mean that a certain type of cancer is present in the body.

Alpha-fetoprotein (AFP) is the most widely used tumor marker for detecting liver cancer. However, other cancers and certain conditions, including pregnancy, hepatitis, and other types of cancer, may also increase AFP levels. Specific tumor markers that may lead to early detection of liver cancer are being studied. (source: NCI)

What do we know about diet and liver cancer?

The Panel concludes (Chapter 7.8 pages 277-280) To download the liver chapter as a pdf click here

The evidence is convincing that aflatoxins, which contaminate mostly cereals (grains) and pulses (legumes), usually as a result of long storage in hot, wet conditions, are a cause of liver cancer.

Alcoholic drinks are probably a cause of liver cancer.

There is limited evidence suggesting that fruits are protective, and that body fatness is a cause of this cancer.  

Source: Second Expert Report: Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. World Cancer Research Fund / American Institute for Cancer Research (WCRF/AICR), Washington DC: AICR, 2007. 537 Pages. Note: PDF file of the complete report is 12 MB in size. More about this report can be found on the “diet” link [or some other name later] of this website. To download the entire report (pdf 12MB) please click here.

• To download a summary of the report (16 pages, pdf 1.2MB) please click here
• To download the report’s summary in other languages than English (WCRF website), please click here

 


 

Resources

MedlinePlus - Liver Cancer Link
MedlinePlus will direct you to information to help answer health questions. MedlinePlus brings together authoritative information from NLM, the National Institutes of Health (NIH), and other government agencies and health-related organizations. MedlinePlus also has extensive information about drugs, an illustrated medical encyclopedia, interactive patient tutorials, and latest health news. To visit MedlinePlus online for Liver Cancer with an extensive, constantly updated resource list please click here

 


 

US GOVERNMENT AND GENERAL RESOURCES

The National Cancer Institute (NCI)
is a component of the National Institutes of Health (NIH), one of eight agencies that compose the Public Health Service (PHS) in the Department of Health and Human Services (DHHS).

The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.

NCI publishes a wealth of information about cancer on the Web. To make it easier for you we have provided direct breast cancer links from NCI below.

Liver (Hepatocellular) Cancer Screening (PDQ) (PDQ, as it is commonly known stands for Physicians Data Query)

Adult Primary Liver Cancer Treatment (PDQ®) (Patient)
Expert-reviewed information summary about the treatment of adult primary liver cancer.

Childhood Liver Cancer Treatment (PDQ®) (Patient)
Expert-reviewed information summary about the treatment of childhood liver cancer.

“What You Need To Know About™ Liver Cancer” NCI’s booklet helps you to learn liver cancer symptoms, diagnosis, treatment, and questions to ask your health care provider. To read the publication, constantly updated, online on the NCI website, please click here

NCI’s booklet “What You Need To Know About™ Liver Cancer” helps you to learn about liver symptoms, diagnosis, treatment, and questions to ask your health care provider. NCI 2006, 51 pages (pdf 2MB). To download the pdf file please click here

American Cancer Society (ACS)
is the nationwide community-based voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives, and diminishing suffering from cancer, through research, education, advocacy, and service. For liver cancer from ACS please click here

ACS: Can Liver Cancer Be Prevented?

For a list of the complete list of Guidelines, from the American Cancer Society (ACS), that are updated constantly, please click here

The American Liver Foundation
was created in 1976 by the American Association for the Study of Liver Disease (AASLD). This organization of scientists and healthcare professionals was concerned with the rising incidence of liver disease and the lack of awareness among both the general public and the medical community. The mission, the programs and the services provided by ALF complement the great work of AASLD.


 

Flyers and brochures

ASCO Answers: Liver Cancer
ASCO Answers is a series of fact sheets that provides an introduction to a specific type of cancer. Each fact sheet is a PDF that includes an overview of what the cancer is, an illustration of where the cancer starts, how it is treated, terms to know, and questions to ask the doctor.
American Society of Clinical Oncology (ASCO) 2008. 2 pages (pdf 292K). To download the pdf please click here

Developing a Health Education Program to Address Liver Cancer in a Community Impacted by Environmental Contamination
Melanie J. Rodriguez, MPH, (no date) Public Center for Environmental Health, San Antonio Metropolitan Health District, San Antonio, Texas. 1 page (pdf 168K). To download the pdf please click here

Hepatitis B Vaccine - What you need to know
CDC 2007, 2 pages, black and white, easy to photocopy.  (pdf 48K). To download the pdf please click here

 


 

Quality Assurance & Improvement

The Pacific Island Health Officers Association
(PIHOA) is dedicated to the health and well-being of the Pacific Island populations.

The links and documents on their website have been selected from a very large body of available materials about quality assurance (QA) and accreditation in health care, with the intention of including those that are especially useful for PIHOA members and their associates who are interested in building QA systems which fit with their local needs. The materials have been grouped into several sections.  To get to the PIHOA quality assurance site please click here

 


 

On-line tools

 

Siteman Cancer Center: Cancer - your disease risk
This interactive tool estimates your risk of cancer and provides personalized tips for prevention. Anyone can use it, but it's most accurate for people age 40 and over who have never had any type of cancer. Please click here

Visuals Online from the National Cancer Institute

NCI Visuals Online contains images from the collections of the Office of Communications and Education and Office of Media Relations, National Cancer Institute. Contents include general biomedical and science-related images, cancer-specific scientific and patient care-related images, and portraits of directors and staff of the National Cancer Institute.
Use of Images

Except where noted on the image details page, Visuals Online images are in the public domain and may be used, linked, or reproduced without permission. If you use an image, you should credit the listed source and/or author. Please click here

 


Journal Articles

Liver cancer in low and middle income countries
Prevention should target vaccination, contaminated needles, and aflatoxins
Editorial, BMJ 2003;326:994-995 ( 10 May ) to read the full text online please click here

 


 

tools and Pacific focus resources

Please click here to open a new page


 

 
 
Principal Investigator: Neal Palafox, MD, MPH:
Program Manager CCC/ Registry: Lee Buenconsejo-Lum, MD 
 Pacific CEED Manager: Karen Heckert, Ph.D., pacificceed@gmail.com
Program Coordinator (Registry): Tricia Eidsmoe, MPA pcregistry@gmail.com
Program Coordinator (CCC): Brian Roberts, MBA pacificcompcancer@gmail.com
 

John A. Burns School of Medicine

University of Hawai‛i at Mānoa

95-390 Kuahelani Avenue

Mililani, Hawai‛i  96789

Copyright © 2008 PacificCancer.org